Where do Jazz Pharmaceuticals's ratios come from?

Every ratio is computed from Jazz Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Free cash flow margin	28.6%-1.8pp	30.4%-1.8pp	32.1%+1.2pp	31%-6.3pp	37.2%+3.9pp
Efficiency
Asset turnover	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×
Liquidity
Current ratio	2×+0.2×	1.9×+0.2×	1.7×0.0×	1.6×-1.8×	3.4×-1.1×
Quick ratio	1.8×+0.2×	1.7×+0.2×	1.4×+0.1×	1.4×-1.6×	3×-1.0×
Cash ratio	0.3×0.0×	0.3×-0.3×	0.6×0.0×	0.6×-0.9×	1.5×-0.8×
Leverage
Debt-to-equity	1.2×-0.1×	1.3×-0.1×	1.4×-0.1×	1.5×+0.2×	1.3×-0.2×
Debt-to-assets	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Per Share
Book value per share	$68.57-3.2%	$70.82+10.2%	$64.26+6.1%	$60.57-11.5%	$68.44+10.4%
Valuation
Market capitalization	$11.64B+12.7%	$10.33B+29.2%	$7.99B+22.2%	$6.54B-13.2%	$7.54B+1.3%
Enterprise value	$16.37B+8.6%	$15.07B+24.8%	$12.08B+12.2%	$10.77B-2.8%	$11.08B-1.0%
Price / sales	2.6×+0.2×	2.4×+0.5×	1.9×+0.3×	1.6×-0.3×	1.9×0.0×
Price / book	2.6×+0.2×	2.4×+0.4×	2×+0.3×	1.8×0.0×	1.8×0.0×
EV / sales	3.7×+0.2×	3.5×+0.6×	2.9×+0.3×	2.6×-0.1×	2.7×0.0×
Free cash flow yield	10.9%-1.6pp	12.6%-4.2pp	16.7%-2.6pp	19.3%-0.7pp	20.1%+1.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Jazz Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Jazz Pharmaceuticals's ratios come from?: Every ratio is computed from Jazz Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.